In mice with acute graft-versus-host disease (GVHD), Norona et al. used the GLP-2 analogue teduglutide [66] and discovered that GLP-2 treatment overcame the deficiency in ISCs caused by graft-versus-host disease and encouraged ISC regeneration. Here, GCG is linked to graft versus host disease.